Biotech and Biometric

Biotech and Biometric

Biotechnology Industry News and Biometrics Technology News

Biotech and Biometric

Biotech and Biometric
Biotechnology Industry News and Biometrics Technology News

Leading Healthcare Solutions Provider Integrates Award-Winning Fingerprint Recognition Solution for HIPAA Compliance

ATLANTA, Ga. -- M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that LOGICARE Corporation has enhanced its OnRecord(TM) healthcare solution for emergency departments and patient educators by integrating M2SYS' Bio-Plugin(TM) fingerprint software.

Epeius Bio Applauds the Belated Scholarship of Their Academic Contemporaries, as Targeted Gene Therapy Comes of Age in 2007

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today their appreciation of the accomplishments of their contemporaries in 2007, a truly remarkable year in terms of biomedical research, scholarship, and gonzo journalism. It was a year in which a definitive meeting entitled "In Vivo Barriers to Gene Delivery" was held at the prestigious Cold Spring Harbor Laboratory, where Nobel laureate James Watson presides, or shall we say presided.

ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G

SAN MARINO, Calif. -- Epeius Biotechnologies Corporation announced today that the company has received a Certificate of Product Registration for Rexin-G(R) from the Philippine Bureau of Food and Drugs (BFAD), enabling the commercialization of its lead product as a safe and effective treatment for a broad spectrum of intractable cancers.

BioIDENTICA SDK Toolkit Now Supports SecuGen Hamster Line of Fingerprint Readers

SANTA CLARA, Calif. -- SecuGen is pleased to announce that Bromba Biometrics BioIDENTICA SDK is now compatible with SecuGen Hamster III, Hamster Plus and Hamster IV fingerprint readers. The BioIDENTICA SDK allows a simple integration of fingerprint technology into any existing or new software application that can benefit from biometric authentication.

SecuGen Fingerprint Readers Now Compatible with Realtime's bioLock Software for SAP Applications

SANTA CLARA, Calif. -- SecuGen is pleased to announce that realtime has integrated SecuGen(R) fingerprint readers with realtime's bioLock Software to provide biometric authentication and fraud mitigation for SAP applications. To date, bioLock is the only certified technology available for ERP market leader, SAP, that offers biometric access and function control.

ZK Software Selects SecuGen Sensor for Access Terminal

SANTA CLARA, Calif. -- SecuGen, a world-leading provider of fingerprint recognition technology, is pleased to announce that ZK Software has selected SecuGen's FDU02 fingerprint sensor for integration with its newly released S900 access control and time & attendance terminal.

Innovative Fingerprint Software Enhances Biometric Time Clock Security and Improves Payroll Productivity

ATLANTA, Ga. -- M2SYS Technology, an award-winning biometric fingerprint technology firm, announced today that Software Techniques Inc. has enhanced their TimeKRON PC-based time and attendance software by integrating M2SYS' Bio-SnapON(TM) solution.

Bioscrypt Selects SecuGen Fingerprint Sensor for V-Station (Optical) Reader

SANTA CLARA, Calif. -- SecuGen is proud to announce that Bioscrypt Inc. (TSX: BYT), a leading provider of identity and access management solutions, has chosen to integrate SecuGen's fingerprint sensor into their V-Station (Optical) reader. With the introduction of the V-Station (Optical), Bioscrypt has added SecuGen's optical sensor technology to its award-winning line of readers for physical access control.

BioSig-ID(TM) Highlighted at 2007 InnoTech Oklahoma

DALLAS, Texas -- Biometric Signature ID ("BSI") announces that CEO, Jeffrey Maynard, will be a speaker at InnoTech, the Business & Technology Innovation Conference to take place at the Cox Convention Center in Oklahoma City. Mr. Maynard will speak Tuesday, November 6, at 10:00 a.m. on a very timely topic entitled "Biometric Signatures to Reduce Identity Theft and Fraud - A New Defense."

Epeius Biotech Leads Keynote on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit

SAN MARINO, Calif. and BOSTON, Mass. -- Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies Inc., has accepted an invitation to give the lead keynote address on "The Advent of Pathotropic Medicine for Cancer" at the Global Pharma R&D Summit 2007 to be held in Boston MA. On October 22, 2007 at 8:00 a.m., Dr. Hall will present the scientific principles, the clinical validation, and global development status.

WHAT'S NEWS